Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer.
Voss MA, Gordon N, Maloney S, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Berditchevski F, Sundar S.
Voss MA, et al.
Br J Cancer. 2011 May 10;104(10):1611-8. doi: 10.1038/bjc.2011.80. Epub 2011 Apr 19.
Br J Cancer. 2011.
PMID: 21505452
Free PMC article.